Part,  Chapter, Paragraph

  1    -,     1            |                over a longer period;~· Analysis of the health determinants
  2    -,     1            |              iii) Data description and analysis; (iv) Risk factors; (v)
  3    I,     2.  1        |                 Figure 2.1).~ ~ ~ ~The analysis of the underlying factors
  4    I,     2.  2        |         updates the Commission’s first analysis of the European tourism
  5    I,     2.  5        |           accession countries into the analysis. The report highlights the
  6    I,     2.  5        |            methodology for comparative analysis and the exchange of good
  7    I,     2. 10.  1    |              genomics and/or in silico analysis to dissect the genetic basis
  8    I,     2. 10.  1    |                to the need for complex analysis in ‘omicstechnologies.~ ~
  9    I,     2. 10.  1    |                 omicstechnologies.~ ~Analysis and exploitation of biodiversity
 10    I,     2. 10.  3    |               standardisation for ICT.~Analysis of the possible application
 11   II,     4.  1        |          eastern countries. A specific analysis made by EHEMU showed that
 12   II,     4.  2        |           birth and at other ages. The analysis of mortality trends is limited
 13   II,     5.  1.  1    |             factors, in a multivariate analysis including age, gender, smoking
 14   II,     5.  2.  3    |                3. Data description and analysis~ ~
 15   II,     5.  2.  3    |               validated, therefore the analysis of temporal trends was not
 16   II,     5.  2.  6    |           reduction? A meta-regression analysis. J Am Coll Cardiol 46: 1855-
 17   II,     5.  3.  2    |         statutory, but cancer survival analysis is illegal.~ ~Lack of dedicated
 18   II,     5.  3.  2    |             cancer research in Europe; analysis and synthesis of National
 19   II,     5.  3.  9    |               Europe: a 200002 period analysis of EUROCARE-4 data. Lancet
 20   II,     5.  4.  2    |         physical examination and blood analysis. ~It is well known that
 21   II,     5.  4.  2    |               request for research and analysis through national/regional
 22   II,     5.  4.  3    |               4.3 Data description and analysis~ ~Comparable data on the
 23   II,     5.  4.  4    |           start collecting data for an analysis of the current health status
 24   II,     5.  5.  1    |                3. Data description and analysis~ ~Prevalence, incidence,
 25   II,     5.  5.  1    |              Europe: a gender-specific analysis of countries participating
 26   II,     5.  5.  2    |                3. Data description and analysis~ ~Prevalence~ ~The prevalence
 27   II,     5.  5.  2    |           prevention strategies and an analysis of the socio-economic cost
 28   II,     5.  5.  3    |               European Union-wide data analysis and comparison of data is
 29   II,     5.  5.  3    |                3. Data description and analysis~ ~Reviewed articles and
 30   II,     5.  5.  3    |                3. Data description and analysis~ ~Data usually representing
 31   II,     5.  5.  3    |              disorders in Europe by an analysis of studies from Italy, Denmark,
 32   II,     5.  5.  3    |              Kingdom. Included in this analysis are psychotic disorders
 33   II,     5.  5.  3    |                3. Data description and analysis~ ~Cross-sectional studies
 34   II,     5.  5.  3    |              as to prevent comparative analysis and do not explain major
 35   II,     5.  5.  3    |               prevent some comparative analysis and do not fully explain
 36   II,     5.  5.  3    |                3. Data description and analysis~ ~In Europe, the incidence,
 37   II,     5.  5.  3    |            confirmed when limiting the analysis to prospective and retrospective
 38   II,     5.  5.  3    |               the different methods of analysis. Patients with severe epilepsy
 39   II,     5.  5.  3    |                3. Data description and analysis~ ~Nearly 200 surveys on
 40   II,     5.  5.  3    |               European wide survey and analysis (Sobocki et al, 2007) revealed
 41   II,     5.  5.  3    |                  in cost-effectiveness analysis. Health Policy and Planning
 42   II,     5.  5.  3    |                3. Data description and analysis~ ~Morbidity and mortality~
 43   II,     5.  5.  3    |          design were selected for this analysis. No studies, however, had
 44   II,     5.  5.  3    |             studies, and a comparative analysis of burden-of-disease, health-related
 45   II,     5.  5.  3    |               on a 3-month prospective analysis. Pharmacoeconomics 14(3):
 46   II,     5.  6.  3    |                3. Data description and analysis~ ~The major musculoskeletal
 47   II,     5.  6.  6    |       fractures of the distal forearm. Analysis of radiographic and other
 48   II,     5.  7.  2    |               used for epidemiological analysis to calculate incidence,
 49   II,     5.  7.  3    |                3. Data description and analysis~ ~Incidence~ ~Children and
 50   II,     5.  7.  5    |               and a cost-effectiveness analysis in support of this contention
 51   II,     5.  7.  7    |             events: a pharmacoeconomic analysis linked to the PREVEND and
 52   II,     5.  7.  7    |           adults: a cost-effectiveness analysis. JAMA 2003;290(23):3101-
 53   II,     5.  8.  3    |                3. Data description and analysis~ ~This section addresses
 54   II,     5.  8.  3    |               2005).~ ~The WHO’s Large Analysis and Review of Housing and
 55   II,     5.  8.  3    |              et al (2007) performed an analysis of mortality in COPD patients
 56   II,     5.  8.  3    |             survival. In the WHO Large Analysis and Review of European Housing
 57   II,     5.  8.  3    |              and 1 261€ in Italy.~ ~An analysis of the Danish Patient Registry
 58   II,     5.  8.  4    |        determinants, in a multivariate analysis including age, gender, smoking
 59   II,     5.  8.  7    |            1979-2002: a multiple cause analysis. Thorax 2006; 61: 930-934.~ ~
 60   II,     5.  8.  7    |                A multiple cause coding analysis. Eur Respir J 2003; 22:
 61   II,     5.  8.  7    |              factors, 2001: systematic analysis of population health data.
 62   II,     5.  9.  3    |                3. Data description and analysis~ ~Incidence and natural
 63   II,     5.  9.  4    |               of the females (P=0.03). Analysis by multiple logistic regression
 64   II,     5.  9.  4    |            change when restricting the analysis to atopic asthma. In conclusion,
 65   II,     5.  9.  7    |            2002): The AIRE Study: data analysis of 753 European children
 66   II,     5. 10.  3    |                3. Data description and analysis~ ~Prevalence of food hypersensitivity~ ~
 67   II,     5. 10.  7    |         allergic disorders in England: analysis of national admissions data.
 68   II,     5. 10.  7    |           Troncone R, Wieser H (2001): Analysis and clinical effects of
 69   II,     5. 11.  3    |                3. Data description and analysis~ ~Diseases of the skin are
 70   II,     5. 11.  3    |         piercings, Engineering Failure Analysis, 2003;10:255263.~DV Belsito,
 71   II,     5. 11.  6    |                 What is clear from the analysis of the available data section
 72   II,     5. 12.  2    |                   Joinpoint regression analysis was used to identify years
 73   II,     5. 12.  2    |                 Kim et al, 2000). This analysis chooses the best fitting
 74   II,     5. 12.  2    |             changes significantly. The analysis starts with the assumption
 75   II,     5. 12.  2    |       predicted trend in the joinpoint analysis, and symbols to represent
 76   II,     5. 12.  3    |                3. Data description and analysis~ ~Graphic representations
 77   II,     5. 12.  3    |              from joinpoint regression analysis of cirrhosis mortality rates
 78   II,     5. 12.  3    |         inference on trends. Joinpoint analysis indicates that the rates
 79   II,     5. 12.  3    |                3. Joinpoint regression analysis for age-standardized cirrhosis
 80   II,     5. 12.  3    |                4. Joinpoint regression analysis for age-standardized cirrhosis
 81   II,     5. 12.  3    |              1970-2002.~ ~This updated analysis of mortality from cirrhosis
 82   II,     5. 12.  7    |                1989: age-period-cohort analysis and changing alcohol consumption.
 83   II,     5. 14.  2    |             used to proceed to a state analysis of trends. A critical analysis
 84   II,     5. 14.  2    |         analysis of trends. A critical analysis of the methodological criteria
 85   II,     5. 14.  2    |               the produced information analysis, research and development
 86   II,     5. 14.  3    |              14.3 Data description and analysis~ ~Dental caries~ ~In a European
 87   II,     5. 14.  3    |        improved in the recent past. An analysis of the literature on this
 88   II,     5. 14.  4    |      adolescents can benefit from diet analysis and modification. Diet analysis,
 89   II,     5. 14.  4    |        analysis and modification. Diet analysis, along with professionally
 90   II,     5. 15.  2    |              is conducting a permanent analysis of published reports providing
 91   II,     5. 15.  3    |                3. Data description and analysis~ ~The distribution of RD
 92   II,     5. 15.  3    |         expectancy is rather short. An analysis of the death certificates
 93   II,     6.  1        |            contains an epidemiological analysis, based on available data
 94   II,     6.  3        |                3. Data description and analysis~ ~
 95   II,     6.  3.  1    |            reported on EU-level.~ ~The analysis of other chapters in this
 96   II,     6.  3.  1    |              of data for more in-depth analysis of risk factors, determinants,
 97   II,     6.  4.  5    |            cooperation will favour the analysis of combined information
 98   II,     6.  4.  5    |           system as regards methods of analysis, sanctions and reporting
 99   II,     7.  3        |                              7.3. Data analysis and presentation~ ~The main
100   II,     7.  4.  1    |          prepared a European situation analysis regarding injuries and risk
101   II,     7.  7        |                 The European Situation Analysis. AdRisk Project. Helsinki,
102   II,     8.  1.  2    |            general. EU-SILC allows the analysis of earnings and income levels
103   II,     8.  1.  2    |             issues, the results of the analysis of the two sets of data (
104   II,     8.  1.  6    |    disabilities in the EU: statistical analysis of the lfs ad hoc module
105   II,     8.  2.  1    |                3. Data description and analysis~ ~Prevalence~ ~The prevalence
106   II,     8.  2.  2    |          people aged 50 or more.~ ~The analysis of the causes of blindness
107   II,     8.  2.  2    |          people aged 50 or more.~ ~The analysis of the causes of blindness
108   II,     8.  2.  2    |    disabilities in the eu: statistical analysis of the LFS ad hoc module
109   II,     8.  2.  3    |    disabilities in the eu: statistical analysis of the LFS ad hoc module
110   II,     9.  1.  1    |               must be combined with an analysis of fetal mortality, since
111   II,     9.  1.  1    |               3. Data presentation and analysis~ ~Foetal, neonatal and infant
112   II,     9.  1.  1    |              hospital payment mode: an analysis based on birth certificates.
113   II,     9.  1.  2    |                3. Data description and analysis~ ~Prevalence of congenital
114   II,     9.  2.  2    |             For instance, the valuable analysis of suicide rates in Europe
115   II,     9.  2.  3    |                3. Data description and analysis~ ~Infants and child (14
116   II,     9.  2.  6    |               higher priority than the analysis of patterns of child mortality.
117   II,     9.  3.  1    |                3. Data description and analysis~ ~Premature death is frequent
118   II,     9.  3.  1    |                in the 35-44 age group. Analysis of cardiovascular diseases
119   II,     9.  3.  1    |              should be assessed by PSA analysis and digital examination
120   II,     9.  3.  1    |               Europe: a 2000-02 period analysis of EUROCARE-4 data." The
121   II,     9.  3.  2    |               3. Data presentation and analysis~ ~Mortality~ ~The EURO-PERISTAT
122   II,     9.  3.  2    |              hospital payment mode: an analysis based on birth certificates.
123   II,     9.  3.  3    |               3. Data presentation and analysis~ ~Mean age at first sexual
124   II,     9.  3.  3    |                of infectious diseases. Analysis of sexual behaviour in the
125   II,     9.  3.  3    |              epidemiology: Comparative analysis in France and Britain. AIDS
126   II,     9.  3.  3    |              gender : a cross-cultural analysis of trends in the 20th century.
127   II,     9.  4.  3    |                3. Data description and analysis~ ~ ~By the year 2025 about
128   II,     9.  5.  3    |                3. Data description and analysis~ ~Health inequalities~ ~
129   II,     9.  5.  4    |                gender awareness, where analysis of the context in which
130  III,    10.  1        | interrelationships and address them in analysis. Due to the high complexity
131  III,    10.  1        |              modelling only allows the analysis of simplified scenarios
132  III,    10.  1.  1    |                for by study design and analysis: e.g. matching, adjustment,
133  III,    10.  1.  3    |                social cognitive theory analysis. Clin Psychol Rev 19(5):
134  III,    10.  2.  1    |                3. Data description and analysis~ ~Prevalence and mortality~ ~
135  III,    10.  2.  1    |                the first comprehensive analysis of global tobacco use and
136  III,    10.  2.  1    |          expected to occur. The global analysis, collated by the WHO from
137  III,    10.  2.  1    |                3. Data description and analysis~Alcohol consumption and
138  III,    10.  2.  1    |              Register-Based Multilevel Analysis of 1.1 Million Men." Social
139  III,    10.  2.  1    |               Grande: a methodological analysis of clinical trials of treatments
140  III,    10.  2.  1    |                3. Data description and analysis~ ~Overall estimates on the
141  III,    10.  2.  1    |                3. Data description and analysis~ ~The Burden of oral hygiene~ ~
142  III,    10.  2.  1    |          relation to oral health, risk analysis focuses on the protective
143  III,    10.  2.  1    |                questions. A scientific analysis of this survey has been
144  III,    10.  2.  1    |                3. Data description and analysis~ ~An analysis of a Eurobarometer
145  III,    10.  2.  1    |          description and analysis~ ~An analysis of a Eurobarometer survey
146  III,    10.  2.  1(20)|                                In this analysis, the cut point for “sufficient
147  III,    10.  2.  1    |                3. Data description and analysis~ ~Overweight and obesity~ ~
148  III,    10.  2.  1    |            morbidity and mortality. An analysis made by the Swedish Institute
149  III,    10.  2.  1    |                a decade: retrospective analysis from a Glasgow Maternity
150  III,    10.  2.  4    |                3. Data description and analysis~ ~In the past twenty years,
151  III,    10.  2.  4    |                focusing on the DNA/RNA analysis technology rather than on
152  III,    10.  2.  5    |                3. Data description and analysis~ ~The Barker theory links
153  III,    10.  2.  5    |               status,~ ~For a detailed analysis of diseases prevalent in
154  III,    10.  3.  1    |                3. Data description and analysis~ ~Radon~ ~Current levels
155  III,    10.  3.  1    |                 Barns, 2005). A pooled analysis of all European epidemiological
156  III,    10.  3.  1    |                and social cost-benefit analysis.~ ~The Green Paper on Future
157  III,    10.  3.  1    |             lung cancer: collaborative analysis of individual data from
158  III,    10.  3.  2    |               3. Data presentation and analysis~ ~Chemical production~ ~
159  III,    10.  3.  2    |            three rounds of breast milk analysis studies of dioxins coordinated
160  III,    10.  3.  2    |                not be confirmed as the analysis methods were not comparable.
161  III,    10.  3.  3    |               3. Data presentation and analysis~ ~Antimicrobial resistance (
162  III,    10.  3.  4    |                3. Data description and analysis~ ~Climatic changes~ ~There
163  III,    10.  3.  4    |               Commission to deepen its analysis. A new Communication is
164  III,    10.  3.  4    |               not allow for a complete analysis of the costs of inaction.
165  III,    10.  3.  4    |            disease surveillance, water analysis and treatment, health education
166  III,    10.  4.  1    |                3. Data description and analysis~ ~Air pollution research
167  III,    10.  4.  1    |               Table 10.4.1.3. The CAFE analysis and the strategy~ ~The need
168  III,    10.  4.  1    |            legislation was revealed by analysis under the CAFE programme
169  III,    10.  4.  1    |             2005b).~Following the CAFE analysis of the various scenarios,
170  III,    10.  4.  2    |            EU-RAIN~European Union Risk Analysis Information Network~FAO~
171  III,    10.  4.  2    |    Manufacturing Practice~HACCP~Hazard Analysis Critical Control Point~IESTI~
172  III,    10.  4.  2    |             political elements of risk analysis, a reference to the precautionary
173  III,    10.  4.  2    |     establishes the principles of risk analysis in relation to food and
174  III,    10.  4.  2    |                the development of risk analysis principles and their subsequent
175  III,    10.  4.  2    |       inter-related components of risk analysis (risk assessment, risk management
176  III,    10.  4.  2    |               the third pillar of risk analysis, requires legislative action
177  III,    10.  4.  2(27)|      procedures for pesticide residues analysis in food and feed, Document
178  III,    10.  4.  2    |             lays down the sampling and analysis methods sampling and analysis
179  III,    10.  4.  2    |          analysis methods sampling and analysis for the official control
180  III,    10.  4.  2    |             lays down the sampling and analysis methods for the official
181  III,    10.  4.  2    |             lays down the sampling and analysis methods of some heavy metals,
182  III,    10.  4.  2    |             lays down the sampling and analysis methods of dioxins and dioxin-like
183  III,    10.  4.  2    |          incongruence in reporting the analysis. Specificity and sensitivity
184  III,    10.  4.  2    |              the design, collation and analysis of a series of baseline
185  III,    10.  4.  2    |                The European Union Risk Analysis Information Network (EU-RAIN)
186  III,    10.  4.  2    |                3. Data description and analysis~ ~Several years ago, the
187  III,    10.  4.  2    |                 GMP) and of the Hazard Analysis Critical Control Point (
188  III,    10.  4.  2    |             European Community.~A risk analysis procedure based on sound
189  III,    10.  4.  2    |            Guidelines for risk-benefit analysis and emerging risks~ ~In
190  III,    10.  4.  2    |           guidelines for “Risk-benefit analysis of foods” and for “the identification
191  III,    10.  4.  2    |         emerging risks”~ ~Risk-benefit analysis~ ~The risk assessment of
192  III,    10.  4.  2    |          consensus that a risk-benefit analysis should mirror the paradigm
193  III,    10.  4.  2    |              well established for risk analysis, consisting of a risk-benefit
194  III,    10.  4.  2    |             addition, the risk-benefit analysis should contain a means(
195  III,    10.  4.  2    |                initiate a risk-benefit analysis should be made on a case-by-case
196  III,    10.  4.  2    |          required to carry out such an analysis, should only be undertaken
197  III,    10.  4.  2    |                why is the risk-benefit analysis being done, why do we need
198  III,    10.  4.  2    |              reasons each risk-benefit analysis needs a narrative up-front
199  III,    10.  4.  2    |              outcome of a risk-benefit analysis, the assumptions made for
200  III,    10.  4.  2    |            made for the assessment and analysis as well as the uncertainties
201  III,    10.  4.  2    |             into account, risk-benefit analysis could improve risk communication
202  III,    10.  4.  2    |         whether the termrisk-benefit analysis” was the appropriate terminology,
203  III,    10.  4.  2    |     terminology such as hazard-benefit analysis or risk-chance [for benefit]
204  III,    10.  4.  2    |              risk-chance [for benefit] analysis for benefit may be more
205  III,    10.  4.  2    |           colloquium on “Risk-benefits analysis of foods: methods and approaches”
206  III,    10.  4.  3    |               3. Data presentation and analysis~ ~Drinking water~ ~Health
207  III,    10.  4.  3    |                out a framework for the analysis, planning and management
208  III,    10.  4.  3    |            process for a comprehensive analysis in order to prepare possible
209  III,    10.  4.  5    |                   Data description and analysis~ ~ ~At present, the general
210  III,    10.  4.  5    |                   Data description and analysis~ ~Waste production~ ~Based
211  III,    10.  4.  5    |            Figure 10.4.5.2.6. Detailed analysis of industrial and commercial
212  III,    10.  4.  5    |          escape formal epidemiological analysis but are relevant for the
213  III,    10.  4.  5    |             the basis of a feasibility analysis aimed at avoiding the execution
214  III,    10.  4.  5    |           timing of exposures, and the analysis of all relevant environmental
215  III,    10.  5.  1    |                3. Data description and analysis~ ~As human settlements are
216  III,    10.  5.  1    |                symptoms in schools: an analysis of existing information.
217  III,    10.  5.  2    |                3. Data description and analysis.~ ~Demographic and contextual
218  III,    10.  5.  2    |              as well, i.e. account all analysis for the age of the respective
219  III,    10.  5.  2    |              and survival from cancer: analysis of Scottish cancer registration.
220  III,    10.  5.  3    |               3.3 Data description and analysis~The burden of diseases to
221  III,    10.  6.  1    |                3. Data description and analysis~ ~Data on social support
222  III,    10.  6.  1    |               and epidemiological data analysis, so that their influence
223  III,    10.  6.  1    |               in the EU. A comparative analysis of the European Survey of
224  III,    10.  6.  2    |                3. Data description and analysis~ ~Among the living and working
225  III,    10.  6.  3    |                published a comparative analysis of crime and safety in Europe (
226  III,    10.  6.  3    |                3. Data description and analysis~ ~Homicides: As far as homicides
227  III,    10.  6.  3    |              are concerned, a detailed analysis has been carried out in
228   IV,    11.  1.  3    |                point for a comparative analysis, although as shown throughout
229   IV,    11.  1.  6    |              of Medicine, 2001).~ ~The analysis of payment mechanisms generally
230   IV,    11.  3.  2    |         consequences to include in the analysis, how to ensure the consistent
231   IV,    11.  3.  2    |          resources needed to undertake analysis. Many countries are now
232   IV,    11.  3.  2    |              France cost-effectiveness analysis is used to inform decisions
233   IV,    11.  4        |      multidisciplinary field of policy analysis. It studies the medical,
234   IV,    11.  4        |         preferences in health economic analysis~Information and data for
235   IV,    11.  5.  4    |        undertake a proper risk-benefit analysis by the transplant team.
236   IV,    11.  6.  4    |               Rice and Smith 2002). An analysis of the risk adjustment schemes
237   IV,    11.  6.  4    |            records), the basic unit of analysis and the variables available
238   IV,    11.  6.  4    |               available for stratified analysis. This information was organised
239   IV,    11.  6.  4    |              to the public (www ). The analysis of collected data showed
240   IV,    11.  6.  4    |           projects.~The results of the analysis will be published on the
241   IV,    11.  6.  5    |           Social Policy: a Comparative Analysis of Taxes, Tax Expenditure
242   IV,    11.  6.  5    |                 41. London, Centre for Analysis of Social Exclusion, London
243   IV,    11.  6.  5    |        Hakkinen U (1998): "Micro-level analysis of distributional changes
244   IV,    12.  2        |                the first comprehensive analysis of global tobacco use and
245   IV,    12.  2        |          expected to occur. The global analysis, compiled by WHO with information
246   IV,    12.  4        |              information, research and analysis.~EU-OSHA~ ~European Agency
247   IV,    12.  5        |                 Develop mechanisms for analysis and dissemination, including
248   IV,    12.  5        |           qualitative and quantitative analysis.~ ~3.3. Provide analysis
249   IV,    12.  5        |               analysis.~ ~3.3. Provide analysis and technical assistance
250   IV,    12.  5        |           platform for the collection, analysis and dissemination of data
251   IV,    13.  2.  2    |            high-income countries.~· An analysis carried out by the Swedish
252   IV,    13.  3        |              stems from many different analysis and particularly from the
253   IV,    13.  7.  1    |              in Europe – A statistical Analysis and Overview of Current
254   IV,    13.  7.  1    |                has to be provided. The analysis presented in the above-mentioned
255   IV,    13.  7.  2    |               year is the result of an analysis of 25 different indicators